Skip to main content

18.11.2019 | Therapeutics and Medical Management (S Jan De Beur and B Clarke, Section Editors) | Ausgabe 6/2019 Open Access

Current Osteoporosis Reports 6/2019

Update on Menopausal Hormone Therapy for Fracture Prevention

Current Osteoporosis Reports > Ausgabe 6/2019
Jan J. Stepan, Hana Hruskova, Miloslav Kverka
Wichtige Hinweise
This article is part of the Topical Collection on Therapeutics and Medical Management

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.


Purpose of Review

The goal of the review is to assess the appropriateness of menopausal hormone therapy (MHT) for the primary prevention of bone loss in women at elevated risk in the early years after menopause.

Recent Findings

Estrogen alone or combined with progestin to protect the uterus from cancer significantly reduces the risk of osteoporosis-related fractures. MHT increases type 1 collagen production and osteoblast survival and maintains the equilibrium between bone resorption and bone formation by modulating osteoblast/osteocyte and T cell regulation of osteoclasts. Estrogens have positive effects on muscle and cartilage. Estrogen, but not antiresorptive therapies, can attenuate the inflammatory bone-microenvironment associated with estrogen deficiency. However, already on second year of administration, MHT is associated with excess breast cancer risk, increasing steadily with duration of use.


MHT should be considered in women with premature estrogen deficiency and increased risk of bone loss and osteoporotic fractures. However, MHT use for the prevention of bone loss is hindered by increase in breast cancer risk even in women younger than 60 years old or who are within 10 years of menopause onset.

Unsere Produktempfehlungen

e.Med Interdisziplinär


Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf Zusätzlich können Sie eine Zeitschrift Ihrer Wahl in gedruckter Form beziehen – ohne Aufpreis.

Jetzt e.Med bestellen und 100 € sparen!

Über diesen Artikel

Weitere Artikel der Ausgabe 6/2019

Current Osteoporosis Reports 6/2019 Zur Ausgabe

Bone Marrow and Adipose Tissue (G Duque and B Lecka-Czernik, Section Editors)

Bone Marrow Adipose Tissue Quantification by Imaging

Biomechanics (G Niebur and J Wallace, Section Editors)

Biomechanics of Osteoporotic Fracture Fixation

Muscle and Bone (L Bonewald and M Hamrick, Section Editors)

Exosomes and Extracellular RNA in Muscle and Bone Aging and Crosstalk

Quality of Care in Osteoporosis (S Silverman and J Curtis, Section Editors)

Quality Measures and Quality Improvement Initiatives in Osteoporosis—an Update

Quality of Care in Osteoporosis (S Silverman and J Curtis, Section Editors)

Bone Health TeleECHO: a Force Multiplier to Improve the Care of Skeletal Diseases in Underserved Communities

Neu im Fachgebiet Orthopädie und Unfallchirurgie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Orthopädie und Unfallchirurgie und bleiben Sie gut informiert – ganz bequem per eMail.